RxSight 2025 Q3 Earnings Net Loss Widens 54.9% Despite Revenue Beat

Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Thursday, Nov 6, 2025 9:14 pm ET1min read
Aime RobotAime Summary

-

(RXST) reported Q3 2025 earnings with a 54.9% wider net loss despite $25.69M in Light Adjustable Lens (LAL) sales.

- Revenue growth was offset by a 68% plummet in LDD unit sales to 25 and persistent operational challenges.

- Post-earnings stock volatility and a maintained "Hold" rating highlight ongoing risks despite revenue outperformance.

RxSight (RXST) reported Q3 2025 earnings on November 6, 2025, . . However, , , underscoring ongoing financial challenges.

Revenue

Light Adjustable Lens (LAL) sales led with $25.69 million, . Service-related revenue, including warranties and accessories, , . , driven by a 68% drop in LDD units sold to 25.

Earnings/Net Income

, . , . , signaling persistent operational headwinds.

Price Action

.

Post-Earnings Price Action Review

, . However, , highlighting risks tied to market volatility. This suggests potential for gains but underscores the need for caution.

CEO Commentary

, . .

Guidance

, , . .

Additional News

, , while maintaining a Hold rating. , , , , .

Comments



Add a public comment...
No comments

No comments yet